Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
Titel:
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
Auteur:
Inoue, A. Kobayashi, K. Maemondo, M. Sugawara, S. Oizumi, S. Isobe, H. Gemma, A. Harada, M. Yoshizawa, H. Kinoshita, I. Fujita, Y. Okinaga, S. Hirano, H. Yoshimori, K. Harada, T. Saijo, Y. Hagiwara, K. Morita, S. Nukiwa, T.